Year: 2018
Type: article
Abstract: This technology could be adapted for HIV-1 vaccine development to present the V1V2 loop in a native-like conformation to induce high titers of binding, neutralizing and functional Abs, T-cell responses targeting multiple epitopes and subdominant epitopes, all of these will hopefully expand upon and improve the results of RV144."
Source: Nanomedicine
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Funder: U.S. Department of Defense
Awards: G4119534169, US MILITARY HIV RESEARCH
OpenAlex ID: W2895464494
